Insider Selling: Oscar Health (NYSE:OSCR) Director Sells $4,618,500.00 in Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 150,000 shares of the stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $30.79, for a total value of $4,618,500.00. Following the transaction, the director owned 480,866 shares in the company, valued at $14,805,864.14. This represents a 23.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $30.24 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a fifty day moving average of $30.32 and a 200 day moving average of $22.48. The firm has a market cap of $9.33 billion, a PE ratio of 21.60, a PEG ratio of 0.61 and a beta of 2.37. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $33.55.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same period last year, the firm posted ($0.89) earnings per share. The company’s revenue was up 70.4% compared to the same quarter last year. As a group, research analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OSCR has been the subject of several research reports. Wells Fargo & Company boosted their price objective on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. The Goldman Sachs Group restated a “neutral” rating and issued a $30.00 price objective on shares of Oscar Health in a report on Tuesday, August 11th. Finally, UBS Group upped their target price on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Oscar Health currently has an average rating of “Hold” and an average target price of $26.22.

Hedge Funds Weigh In On Oscar Health

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares during the period. Geode Capital Management LLC lifted its stake in shares of Oscar Health by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after purchasing an additional 116,430 shares during the last quarter. BIT Capital GmbH grew its holdings in shares of Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the period. Simplify Asset Management Inc. acquired a new stake in shares of Oscar Health during the 4th quarter worth about $2,948,000. Finally, Fortis Group Advisors LLC increased its position in shares of Oscar Health by 82.9% during the 4th quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock worth $2,724,000 after purchasing an additional 86,035 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.